Xenetic Biosciences Inc. (XBIO)
Market Open
12 Jun, 17:42
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
3. 27
+0.27
+8.8333%
$
5.67M Market Cap
- P/E Ratio
- Div Yield
14,528 Volume
0 Eps
$ 3
Previous Close Investors:
Want to track XBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Xenetic Biosciences Inc. (XBIO) Statistics
Valuation metrics
Market Cap 5.67M
Enterprise value -1.51M
Trailing P/E (ttm) -3.17
Forward P/E -
PEG ratio -0.05
Price/Sales (ttm) 1.83
Price/Book (mrq) 1.02
Enterprise Value/Revenue -0.47
Enterprise Value/EBITDA 0.64
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 22.1K
Average volume (90 days) 19.88K
Price summary
52-Week low 1.9
52-Week high 13.93
Beta -
50-Day moving average 3.12
200-Day moving average 2.66
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 15 May 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.7%
Operating margin -0.75%
Operational effectiveness
Return on assets -0.28%
Return on equity -0.39%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.39
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.98
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.21
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 7.93%
Book value per share (mrq) 3.03
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
